Microneedles: A New Frontier in Nanomedicine Delivery

Pharmaceutical Research

Volumn 33, Issue 5, 2016, Pages 1055-1073

  Larrañeta, Eneko ^a   McCrudden, Maelíosa T C ^a   Courtenay, Aaron J ^a   Donnelly, Ryan F ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

drug delivery; microneedles; microparticles; nanomedicine; nanoparticles; vaccines

Indexed keywords

METAL NANOPARTICLE; MINERAL; NANOCARRIER; NANOPARTICLE; NANOSTRUCTURED LIPID CARRIER; OVALBUMIN; POLYMER; SOLID LIPID NANOPARTICLE; UNCLASSIFIED DRUG; VACCINE; DRUG; DRUG CARRIER;

ADAPTIVE IMMUNITY; DRUG DELIVERY SYSTEM; EPIDERMIS; HUMAN; HYDROGEL; IMMUNOGENICITY; LIPID BILAYER; LIPID VESICLE; MECHANICAL STRESS; METHODOLOGY; MICROCIRCULATION; MICROEMULSION; MICRONEEDLE; NANOMEDICINE; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PARTICLE SIZE; PHYSICAL CHEMISTRY; POLYMERIZATION; PRIORITY JOURNAL; REVIEW; SKIN ABSORPTION; SKIN APPENDAGE; SKIN PENETRATION; SKIN PERMEABILITY; SKIN STRUCTURE; SKIN SURFACE; TRANSDERMAL DRUG DELIVERY SYSTEM; ANIMAL; CHEMISTRY; CUTANEOUS DRUG ADMINISTRATION; DEVICES; METABOLISM; MICROINJECTION; NEEDLE; PHARMACOKINETICS; SKIN; ULTRASTRUCTURE; VACCINATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; MICROINJECTIONS; NANOMEDICINE; NANOPARTICLES; NEEDLES; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; SKIN; SKIN ABSORPTION; VACCINATION; VACCINES;

EID: 84959104625     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-016-1885-5     Document Type: Review

References (153)

1. Wagner V, Dullaart A, Bock AK, Zweck A. The emerging nanomedicine landscape. Nat Biotechnol. 2006;24(10):1211-7.
2. Moghimi SM, Hunter AC, Murray JC. Nanomedicine: current status and future prospects. FASEB J. 2005;19(3):311-30.
3. Parveen S, Misra R, Sahoo SK. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine. 2012;8(2):147-66.
4. Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W, et al. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev. 2011;63(6):470-91.
5. Patravale V, Dandekar P, Jain R. Nanoparticulate drug delivery: perspectives on the transition from laboratory to market: Elsevier Science; 2012.
6. Kumar CSSR. Nanomaterials for medical diagnosis and therapy: Wiley; 2007.
7. Donnelly RF, Singh TRR, Morrow DIJ, Woolfson AD. Microneedle-mediated transdermal and intradermal drug delivery: Wiley; 2012.
8. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26(11):1261-8.
9. Agüeros M, Espuelas S, Esparza I, Calleja P, Peñuelas I, Ponchel G, et al. Cyclodextrin-poly(anhydride) nanoparticles as new vehicles for oral drug delivery. Expert Opin Drug Deliv. 2011;8(6):721-34.
10. Ponchel G, Irache JM. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Deliv Rev. 1998;34(2-3):191-219.
11. Torchilin V. Handbook of nanobiomedical research: fundamentals, applications and recent developments: World Scientific Publishing Company; 2014.
12. Miller MA, Pisani E. The cost of unsafe injections. Bull World Health Organ. 1999;77(10):808-11.
13. Smith HW, Clowes GHA, Marshall EK. On dichloroethylsulphide (mustard gas). IV, the mechanism of absorption by the skin. J Pharm Exp Ther. 1919;13(1):1-30.
14. Scheuplein RJ. Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration. J Invest Dermatol. 1967;48(1):79-88.
15. Hadgraft J. Transdermal drug delivery systems: revised and expanded: CRC Press; 2002.
16. Williams A. Transdermal and topical drug delivery from theory to clinical practice: Pharmaceutical Press; 2003.
17. Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004;3(2):115-24.
18. Bronaugh RL, Maibach HI. Percutaneous absorption: drugs-cosmetics-mechanisms-methodology: drugs-cosmetics-mechanisms-methodology, 3rd ed.: CRC Press; 1999.
19. Donnelly RF, Singh TRR. Novel delivery systems for transdermal and intradermal drug delivery: Wiley; 2015.
20. Baroli B. Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? J Pharm Sci. 2010;99(1):21-50.
21. Quinn HL, Kearney MC, Courtenay AJ, McCrudden MT, Donnelly RF. The role of microneedles for drug and vaccine delivery. Expert Opin Drug Deliv. 2014;11(11):1769-80.
22. Prausnitz MR. Microneedles for transdermal drug delivery. Adv Drug Deliv Rev. 2004;56(5):581-7.
23. Tuan-Mahmood TM, McCrudden MT, Torrisi BM, McAlister E, Garland MJ, Singh TR, et al. Microneedles for intradermal and transdermal drug delivery. Eur J Pharm Sci. 2013;50(5):623-37.
24. Donnelly RF, Mooney K, Caffarel-Salvador E, Torrisi BM, Eltayib E, McElnay JC. Microneedle-mediated minimally invasive patient monitoring. Ther Drug Monit. 2014;36(1):10-7.
25. Mooney K, McElnay JC, Donnelly RF. Children's views on microneedle use as an alternative to blood sampling for patient monitoring. Int J Pharm Pract. 2014;22(5):335-44.
26. Chuong CM, Nickoloff BJ, Elias PM, Goldsmith LA, Macher E, Maderson PA, et al. What is the 'true' function of skin? Exp Dermatol. 2002;11(2):159-63.
27. Jepps OG, Dancik Y, Anissimov YG, Roberts MS. Modeling the human skin barrier - Towards a better understanding of dermal absorption. Adv Drug Deliv Rev. 2013;65(2):152-68.
28. Krieg T, Bickers DR, Miyachi Y. Therapy of skin diseases: a worldwide perspective on therapeutic approaches and their molecular basis. Berlin Heidelberg: Springer; 2010.
29. Wiechers JW. The barrier function of the skin in relation to percutaneous absorption of drugs. Pharm Weekblad Sci. 1989;11(6):185-98.
30. Michaels AS, Chandrasekaran SK, Shaw JE. Drug permeation through human skin: theory andinvitro experimental measurement. AICHE J. 1975;21(5):985-96.
31. Bouwstra JA, Gooris GS, van der Spek JA, Bras W. Structural investigations of human stratum corneum by small-angle X-Ray scattering. J Invest Dermatol. 1991;97(6):1005-12.
32. Tso CP, Zhung CM, Shih YH, Tseng YM, Wu SC, Doong RA. Stability of metal oxide nanoparticles in aqueous solutions. Water Sci Technol. 2010;61(1):127-33.
33. Schneider M, Stracke F, Hansen S, Schaefer UF. Nanoparticles and their interactions with the dermal barrier. Dermatoendocrinol. 2009;1(4):197-206.
34. Cevc G, Vierl U. Nanotechnology and the transdermal route: a state of the art review and critical appraisal. J Control Release. 2010;141(3):277-99.
35. Elsayed MMA, Abdallah OY, Naggar VF, Khalafallah NM. Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm. 2007;332(1-2):1.
36. Pierre MB, Dos Santos Miranda Costa I. Liposomal systems as drug delivery vehicles for dermal and transdermal applications. Arch Dermatol Res. 2011;303(9):607-21.
37. Mura P, Maestrelli F, González-Rodríguez ML, Michelacci I, Ghelardini C, Rabasco AM. Development, characterization and in vivo evaluation of benzocaine-loaded liposomes. Eur J Pharm Biopharm. 2007;67(1):86.
38. Taddio A, Soin HK, Schuh S, Koren G, Scolnik D. Liposomal lidocaine to improve procedural success rates and reduce procedural pain among children: a randomized controlled trial. Can Med Assoc J. 2005;172(13):1691-5.
39. Simões SI, Delgado TC, Lopes RM, Jesus S, Ferreira AA, Morais JA, et al. Developments in the rat adjuvant arthritis model and its use in therapeutic evaluation of novel non-invasive treatment by \SOD\ in Transfersomes. J Control Release. 2005;103(2):419.
40. Paolino D, Lucania G, Mardente D, Alhaique F, Fresta M. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. J Control Release. 2005;106(1):99-110.
41. Maestrelli F, González-Rodríguez ML, Rabasco AM, Mura P. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery. Int J Pharm. 2006;312(1-2):53.
42. Schäfer-Korting M, Mehnert W, Korting HC. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev. 2007;59(6):427-43.
43. Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54(Supplement):S131.
44. Vogt A, Combadiere B, Hadam S, Stieler KM, Lademann J, Schaefer H, et al. 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a + Cells after transcutaneous application on human skin. J Invest Dermatol. 2006;126(6):1316-22.
45. Alvarez-Román R, Naik A, Kalia YN, Guy RH, Fessi H. Skin penetration and distribution of polymeric nanoparticles. J Control Release. 2004;99(1):53.
46. Lopes LB. Overcoming the cutaneous barrier with microemulsions. Pharmaceutics. 2014;6(1):52-77.
47. Zhang Z, Tsai PC, Ramezanli T, Michniak-Kohn B. Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013;5(3):205-18.
48. Kim DG, Jeong YI, Choi C, Roh SH, Kang SK, Jang MK, et al. Retinol-encapsulated low molecular water-soluble chitosan nanoparticles. Int J Pharm. 2006;319(1-2):130-8.
49. Hasanovic A, Zehl M, Reznicek G, Valenta C. Chitosan-tripolyphosphate nanoparticles as a possible skin drug delivery system for aciclovir with enhanced stability. J Pharm Pharmacol. 2009;61(12):1609-16.
50. Tomoda K, Terashima H, Suzuki K, Inagi T, Terada H, Makino K. Enhanced transdermal delivery of indomethacin-loaded PLGA nanoparticles by iontophoresis. Colloids Surf, B Biointerfaces. 2011;88(2):706-10.
51. Shah PP, Desai PR, Patel AR, Singh MS. Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs. Biomaterials. 2012;33(5):1607-17.
52. Kreilgaard M. Influence of microemulsions on cutaneous drug delivery. Adv Drug Deliv Rev. 2002;54(Supplement):S77-98.
53. Wu H, Ramachandran C, Bielinska AU, Kingzett K, Sun R, Weiner ND, et al. Topical transfection using plasmid DNA in a water-in-oil nanoemulsion. Int J Pharm. 2001;221(1-2):23-34.
54. Pakpayat N, Nielloud F, Fortuné R, Tourne-Peteilh C, Villarreal A, Grillo I, et al. Formulation of ascorbic acid microemulsions with alkyl polyglycosides. Eur J Pharm Biopharm. 2009;72(2):444-52.
55. Lopes LB, VanDeWall H, Li HT, Venugopal V, Li HK, Naydin S, et al. Topical delivery of lycopene using microemulsions: enhanced skin penetration and tissue antioxidant activity. J Pharm Sci. 2010;99(3):1346-57.
56. Baroli B, Ennas MG, Loffredo F, Isola M, Pinna R, Lopez-Quintela M. Penetration of metallic nanoparticles in human full-thickness skin. J Invest Dermatol. 2007;127(7):1701-12.
57. Yong KT. Quantum dots for biophotonics. Theranostics. 2012;2(7):629-30.
58. Prow TW, Monteiro-Riviere NA, Inman AO, Grice JE, Chen X, Zhao X, et al. Quantum dot penetration into viable human skin. Nanotoxicology. 2012;6(2):173-85.
59. Zhang LW, Yu WW, Colvin VL, Monteiro-Riviere NA. Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. Toxicol Appl Pharmacol. 2008;228(2):200-11.
60. Ryman-Rasmussen JP, Riviere JE, Monteiro-Riviere NA. Penetration of Intact skin by quantum dots with diverse physicochemical properties. Toxicol Sci. 2006;91(1):159-65.
61. Zhang LW, Monteiro-Riviere NA. Assessment of quantum dot penetration into intact, tape-stripped, abraded and flexed rat skin. Skin Pharmacol Physiol. 2008;21(3):166-80.
62. Chu MQ, Wu Q, Wang JX, Hou SK, Miao Y, Peng JL, et al. In vitro and in vivo transdermal delivery capacity of quantum dots through mouse skin. Nanotechnology. 2007;18(45):455103.
63. Nohynek GJ, Lademann J, Ribaud C, Roberts MS. Grey Goo on the Skin? Nanotechnology, cosmetic and sunscreen safety. Crit Rev Toxicol. 2007;37(3):251-77.
64. Kimura E, Kawano Y, Todo H, Ikarashi Y, Sugibayashi K. Measurement of skin permeation/Penetration of nanoparticles for their safety evaluation. Biol Pharm Bull. 2012;35(9):1476-86.
65. Byszewski P, Klusek Z. Some properties of fullerenes and carbon nanotubes. Opto-Electron Rev. 2001;9(2):203-10.
66. Rouse JG, Yang J, Ryman-Rasmussen J, Barron AR, Monteiro-Riviere N. Effects of mechanical flexion on the penetration of fullerene amino acid-derivatized peptide nanoparticles through skin. Nano Lett. 2007;7(1):155-60.
67. Siu KS, Chen D, Zheng X, Zhang X, Johnston N, Liu Y, et al. Non-covalently functionalized single-walled carbon nanotube for topical siRNA delivery into melanoma. Biomaterials. 2014;35(10):3435-42.
68. Degim IT, Burgess DJ, Papadimitrakopoulos F. Carbon nanotubes for transdermal drug delivery. J Microencapsul. 2010;27(8):669-81.
69. Donnelly RF, Morrow DIJ, McCarron PA, Woolfson AD, Morrissey A, Juzenas P, et al. Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy. J Control Release. 2008;129(3):154-62.
70. Indermun S, Luttge R, Choonara YE, Kumar P, du Toit LC, Modi G, et al. Current advances in the fabrication of microneedles for transdermal delivery. J Control Release. 2014;185:130-8.
71. Li WZ, Huo MR, Zhou JP, Zhou YQ, Hao BH, Liu T, et al. Super-short solid silicon microneedles for transdermal drug delivery applications. Int J Pharm. 2010;389(1-2):122-9.
72. O'Mahony C. Structural characterization and in-vivo reliability evaluation of silicon microneedles. Biomed Microdevices. 2014;16(3):333-43.
73. Donnelly RF, Morrow DI, McCarron PA, Woolfson AD, Morrissey A, Juzenas P, et al. Microneedle arrays permit enhanced intradermal delivery of a preformed photosensitizer. Photochem Photobiol. 2009;85(1):195-204.
74. Oh JH, Park HH, Do KY, Han M, Hyun DH, Kim CG, et al. Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein. Eur J Pharm Biopharm. 2008;69(3):1040-5.
75. McAllister DV, Wang PM, Davis SP, Park JH, Canatella PJ, Allen MG, et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci U S A. 2003;100(24):13755-60.
76. Wermeling DP, Banks SL, Hudson DA, Gill HS, Gupta J, Prausnitz MR, et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc Natl Acad Sci U S A. 2008;105(6):2058-63.
77. Qin G, Gao Y, Wu Y, Zhang S, Qiu Y, Li F, et al. Simultaneous basal-bolus delivery of fast-acting insulin and its significance in diabetes management. Nanomedicine. 2012;8(2):221-7.
78. Gill HS, Prausnitz MR. Coated microneedles for transdermal delivery. J Control Release. 2007;117(2):227-37.
79. Vrdoljak A, McGrath MG, Carey JB, Draper SJ, Hill AV, O'Mahony C, et al. Coated microneedle arrays for transcutaneous delivery of live virus vaccines. J Control Release. 2012;159(1):34-42.
80. Davidson A, Al-Qallaf B, Das DB. Transdermal drug delivery by coated microneedles: geometry effects on effective skin thickness and drug permeability. Chem Eng Res Des. 2008;86(11):1196-206.
81. Cormier M, Johnson B, Ameri M, Nyam K, Libiran L, Zhang DD, et al. Transdermal delivery of desmopressin using a coated microneedle array patch system. J Control Release. 2004;97(3):503-11.
82. Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR. Formulation of microneedles coated with influenza virus-like particle vaccine. AAPS PharmSciTech. 2010;11(3):1193-201.
83. Chen X, Prow TW, Crichton ML, Jenkins DW, Roberts MS, Frazer IH, et al. Dry-coated microprojection array patches for targeted delivery of immunotherapeutics to the skin. J Control Release. 2009;139(3):212-20.
84. Chong RH, Gonzalez-Gonzalez E, Lara MF, Speaker TJ, Contag CH, Kaspar RL, et al. Gene silencing following siRNA delivery to skin via coated steel microneedles: In vitro and in vivo proof-of-concept. J Control Release. 2013;166(3):211-9.
85. Ito Y, Hirono M, Fukushima K, Sugioka N, Takada K. Two-layered dissolving microneedles formulated with intermediate-acting insulin. Int J Pharm. 2012;436(1-2):387-93.
86. Liu S, Jin MN, Quan YS, Kamiyama F, Katsumi H, Sakane T, et al. The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin. J Control Release. 2012;161(3):933-41.
87. Gomaa YA, Garland MJ, McInnes F, El-Khordagui LK, Wilson C, Donnelly R. Laser-engineered dissolving microneedles for active transdermal delivery of nadroparin calcium. Eur J Pharm Biopharm. 2012;82(2):299-307.
88. Naito S, Ito Y, Kiyohara T, Kataoka M, Ochiai M, Takada K. Antigen-loaded dissolving microneedle array as a novel tool for percutaneous vaccination. Vaccine. 2012;30(6):1191-7.
89. Matsuo K, Yokota Y, Zhai Y, Quan YS, Kamiyama F, Mukai Y, et al. A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens. J Control Release. 2012;161(1):10-7.
90. Matsuo K, Hirobe S, Yokota Y, Ayabe Y, Seto M, Quan YS, et al. Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza. J Control Release. 2012;160(3):495-501.
91. Donnelly RF, Morrow DI, McCrudden MT, Alkilani AZ, Vicente-Pérez EM, O'Mahony C, et al. Hydrogel-forming and dissolving microneedles for enhanced delivery of photosensitizers and precursors. Photochem Photobiol. 2014;90(3):641-7.
92. McCrudden MT, Alkilani AZ, McCrudden CM, McAlister E, McCarthy HO, Woolfson AD, et al. Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs. J Control Release. 2014;180:71-80.
93. Garland MJ, Caffarel-Salvador E, Migalska K, Woolfson AD, Donnelly RF. Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery. J Control Release. 2012;159(1):52-9.
94. Roxhed N, Samel B, Nordquist L, Griss P, Stemme G. Painless drug delivery through microneedle-based transdermal patches featuring active infusion. IEEE Trans Biomed Eng. 2008;55(3):1063-71.
95. Chandrasekaran S, Frazier AB. Characterization of surface micromachined metallic microneedles. J Microelectromech Syst. 2003;12(3):289-95.
96. Wang PM, Cornwell M, Hill J, Prausnitz MR. Precise microinjection into skin using hollow microneedles. J Invest Dermatol. 2006;126(5):1080-7.
97. Sammoura F, Kang JJ, Heo YM, Jung TS, Lin LW. Polymeric microneedle fabrication using a microinjection molding technique. Microsyst Technol. 2007;13(5-6):517-22.
98. Ovsianikov A, Chichkov B, Mente P, Monteiro-Riviere NA, Doraiswamy A, Narayan RJ. Two photon polymerization of polymer-ceramic hybrid materials for transdermal drug delivery. Int J Appl Ceram Technol. 2007;4(1):22-9.
99. Davis SP, Martanto W, Allen MG, Prausnitz MR. Hollow metal microneedles for insulin delivery to diabetic rats. IEEE Trans Biomed Eng. 2005;52(5):909-15.
100. Donnelly RF, Singh TR, Alkilani AZ, McCrudden MT, O'Neill S, O'Mahony C, et al. Hydrogel-forming microneedle arrays exhibit antimicrobial properties: potential for enhanced patient safety. Int J Pharm. 2013;451(1-2):76-91.
101. Donnelly RF, Singh TRR, Garland MJ, Migalska K, Majithiya R, McCrudden CM, et al. Hydrogel-forming microneedle arrays for enhanced transdermal drug delivery. Adv Funct Mater. 2012;22(23):4879-90.
102. Donnelly RF, McCrudden MTC, Zaid Alkilani A, Larrañeta E, McAlister E, Courtenay AJ, et al. Hydrogel-forming microneedles prepared from "Super Swelling" polymers combined with lyophilised wafers for transdermal drug delivery. PLoS One. 2014;9(10):e111547.
103. Larrañeta E, Lutton REM, Brady AJ, Vicente-Pérez EM, Woolfson AD, Thakur RRS, et al. Microwave-assisted preparation of hydrogel-forming microneedle arrays for transdermal drug delivery applications. Macromol Mater Eng. 2015;300(6):586-95.
104. Hong X, Wu Z, Chen L, Wu F, Wei L, Yuan W. Hydrogel microneedle arrays for transdermal drug delivery. Nano-Micro Lett. 2014;6(3):191-9.
105. McCrudden MT, Alkilani AZ, Courtenay AJ, McCrudden CM, McCloskey B, Walker C, et al. Considerations in the sterile manufacture of polymeric microneedle arrays. Drug Deliv Transl Res. 2015;5(1):3-14.
106. Coulman SA, Anstey A, Gateley C, Morrissey A, McLoughlin P, Allender C, et al. Microneedle mediated delivery of nanoparticles into human skin. Int J Pharm. 2009;366(1-2):190-200.
107. Zhang W, Gao J, Zhu Q, Zhang M, Ding X, Wang X, et al. Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles. Int J Pharm. 2010;402(1-2):205-12.
108. Gomaa YA, Garland MJ, McInnes FJ, Donnelly RF, El-Khordagui LK, Wilson CG. Microneedle/nanoencapsulation-mediated transdermal delivery: mechanistic insights. Eur J Pharm Biopharm. 2014;86(2):145-55.
109. Zhang D, Das DB, Rielly CD. An experimental study of microneedle-assisted microparticle delivery. J Pharm Sci. 2013;102(10):3632-44.
110. Zhang D, Das DB, Rielly CD. Microneedle assisted micro-particle delivery from gene guns: experiments using skin-mimicking agarose gel. J Pharm Sci. 2014;103(2):613-27.
111. Häfeli UO, Mokhtari A, Liepmann D, Stoeber B. In vivo evaluation of a microneedle-based miniature syringe for intradermal drug delivery. Biomed Microdevices. 2009;11(5):943-50.
112. Park JH, Choi SO, Kamath R, Yoon YK, Allen MG, Prausnitz MR. Polymer particle-based micromolding to fabricate novel microstructures. Biomed Microdevices. 2007;9(2):223-34.
113. Jiang J, Moore J, Edelhauser H, Prausnitz M. Intrascleral drug delivery to the eye using hollow microneedles. Pharm Res. 2009;26(2):395-403.
114. Patel SR, Lin AS, Edelhauser HF, Prausnitz MR. Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharm Res. 2011;28(1):166-76.
115. Kim YC, Edelhauser HF, Prausnitz MR. Particle-stabilized emulsion droplets for gravity-mediated targeting in the posterior segment of the eye. Adv Healthc Mater. 2014;3(8):1272-82.
116. DeMuth PC, Su X, Samuel RE, Hammond PT, Irvine DJ. Nano-layered microneedles for transcutaneous delivery of polymer nanoparticles and plasmid DNA. Adv Mater. 2010;22(43):4851.
117. Chiappini C, Martinez JO, De Rosa E, Almeida CS, Tasciotti E, Stevens MM. Biodegradable nanoneedles for localized delivery of nanoparticles in vivo: exploring the biointerface. ACS Nano. 2015;9(5):5500-9.
118. Ito Y, Hagiwara E, Saeki A, Sugioka N, Takada K. Sustained-release self-dissolving micropiles for percutaneous absorption of insulin in mice. J Drug Target. 2007;15(5):323-6.
119. Chen H, Zhu H, Zheng J, Mou D, Wan J, Zhang J, et al. Iontophoresis-driven penetration of nanovesicles through microneedle-induced skin microchannels for enhancing transdermal delivery of insulin. J Control Release. 2009;139(1):63-72.
120. Yu J, Zhang Y, Ye Y, DiSanto R, Sun W, Ranson D, et al. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery. Proc Natl Acad Sci U S A. 2015;112(27):8260-5.
121. Ma Y, Boese S, Luo Z, Nitin N, Gill H. Drug coated microneedles for minimally-invasive treatment of oral carcinomas: development and in vitroevaluation. Biomed Microdevices. 2015;17(2):1.
122. Paleco R, Vučen SR, Crean AM, Moore A, Scalia S. Enhancement of the in vitro penetration of quercetin through pig skin by combined microneedles and lipid microparticles. Int J Pharm. 2014;472(1-2):206-13.
123. Vučen SR, Vuleta G, Crean AM, Moore AC, Ignjatović N, Uskoković D. Improved percutaneous delivery of ketoprofen using combined application of nanocarriers and silicon microneedles. J Pharm Pharmacol. 2013;65(10):1451-62.
124. Donnelly RF, Morrow DIJ, Fay F, Scott CJ, Abdelghany S, Singh RRT, et al. Microneedle-mediated intradermal nanoparticle delivery: potential for enhanced local administration of hydrophobic pre-formed photosensitisers. Photodiagnosis Photodyn Ther. 2010;7(4):222-31.
125. Gomaa YA, El-Khordagui LK, Garland MJ, Donnelly RF, McInnes F, Meidan VM. Effect of microneedle treatment on the skin permeation of a nanoencapsulated dye. J Pharm Pharmacol. 2012;64(11):1592-602.
126. Ke CJ, Lin YJ, Hu YC, Chiang WL, Chen KJ, Yang WC, et al. Multidrug release based on microneedle arrays filled with pH-responsive PLGA hollow microspheres. Biomaterials. 2012;33(20):5156-65.
127. Lee SG, Jeong JH, Lee KM, Jeong KH, Yang H, Kim M, et al. Nanostructured lipid carrier-loaded hyaluronic acid microneedles for controlled dermal delivery of a lipophilic molecule. Int J Nanomedicine. 2014;9:289-99.
128. Justin R, Román S, Chen D, Tao K, Geng X, Grant RT, et al. Biodegradable and conductive chitosan-graphene quantum dot nanocomposite microneedles for delivery of both small and large molecular weight therapeutics. RSC Adv. 2015;5(64):51934-46.
129. Zaric M, Lyubomska O, Touzelet O, Poux C, Al-Zahrani S, Fay F, et al. Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D, L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses. ACS Nano. 2013;7(3):2042-55.
130. Storni T, Kündig TM, Senti G, Johansen P. Immunity in response to particulate antigen-delivery systems. Adv Drug Deliv Rev. 2005;57(3):333-55.
131. Gutierro I, Hernandez RM, Igartua M, Gascon AR, Pedraz JL. Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres. Vaccine. 2002;21(1-2):67-77.
132. Jaganathan KS, Vyas SP. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant Hepatitis B antigen administered intranasally. Vaccine. 2006;24(19):4201-11.
133. Mahapatro A, Singh DK. Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnol. 2011;9(1):55.
134. De Geest BG, Willart MA, Hammad H, Lambrecht BN, Pollard C, Bogaert P, et al. Polymeric multilayer capsule-mediated vaccination induces protective immunity against cancer and viral infection. ACS Nano. 2012;6(3):2136-49.
135. Bal SM, Slütter B, Jiskoot W, Bouwstra JA. Small is beautiful: N-trimethyl chitosan-ovalbumin conjugates for microneedle-based transcutaneous immunisation. Vaccine. 2011;29(23):4025-32.
136. Kumar A, Li XR, Sandoval MA, Rodriguez BL, Sloat BR, Cui ZR. Permeation of antigen protein-conjugated nanoparticles and live bacteria through microneedle-treated mouse skin. Int J Nanomedicine. 2011;6:1253-64.
137. Kumar A, Wonganan P, Sandoval MA, Li X, Zhu S, Cui Z. Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticles. J Control Release. 2012;163(2):230-9.
138. McCaffrey J, McCrudden CM, Ali AA, Massey AS, McBride JW, McCrudden MTC, et al. Transcending epithelial and intracellular biological barriers; a prototype DNA delivery device. J Control Release Submitted.
139. McCarthy HO, McCaffrey J, McCrudden CM, Zholobenko A, Ali AA, McBride JW, et al. Development and characterization of self-assembling nanoparticles using a bio-inspired amphipathic peptide for gene delivery. J Control Release. 2014;189(1):141-9.
140. Bennett R, Yakkundi A, McKeen HD, McClements L, McKeogh TJ, McCrudden CM, et al. RALA-mediated delivery of FKBPL nucleic acid therapeutics. Nanomedicine. 2015;10(19):2989-3001.
141. DeMuth PC, Garcia-Beltran WF, Ai-Ling ML, Hammond PT, Irvine DJ. Composite dissolving microneedles for coordinated control of antigen and adjuvant delivery kinetics in transcutaneous vaccination. Adv Funct Mater. 2013;23(2):161-72.
142. Zaric M, Lyubomska O, Poux C, Hanna ML, McCrudden MT, Malissen B, et al. Dissolving microneedle delivery of nanoparticle-encapsulated antigen elicits efficient cross-priming and Th1 immune responses by murine langerhans cells. J Invest Dermatol. 2015;135(2):425-34.
143. Kim NW, Lee MS, Kim KR, Lee JE, Lee K, Park JS, et al. Polyplex-releasing microneedles for enhanced cutaneous delivery of DNA vaccine. J Control Release. 2014;179:11-7.
144. Hu Y, Xu B, Xu J, Shou D, Liu E, Gao J, et al. Microneedle-assisted dendritic cell-targeted nanoparticles for transcutaneous DNA immunization. Polym Chem. 2015;6(3):373-9.
145. Kim CS, Wilder-Smith P, Ahn YC, Liaw LHL, Chen Z, Kwon YJ. Enhanced detection of early-stage oral cancer in vivo by optical coherence tomography using multimodal delivery of gold nanoparticles. J Biomed Opt. 2009;14(3):034008.
146. Kim CS, Ahn YC, Wilder-Smith P, Oh S, Chen Z, Kwon YJ. Efficient and facile delivery of gold nanoparticles in vivo using dissolvable microneedles for contrast-enhanced optical coherence tomography. Biomed Opt Express. 2010;1(1):106-13.
147. Gittard SD, Miller PR, Boehm RD, Ovsianikov A, Chichkov BN, Heiser J, et al. Multiphoton microscopy of transdermal quantum dot delivery using two photon polymerization-fabricated polymer microneedles. Faraday Discuss. 2011;149(1):171-85.
148. Doraiswamy A, Ovsianikov A, Gittard SD, Monteiro-Riviere NA, Crombez R, Montalvo E, et al. Fabrication of microneedles using two photon polymerization for transdermal delivery of nanomaterials. J Nanosci Nanotechnol. 2010;10(10):6305-12.
149. Raja WK, Maccorkle S, Diwan IM, Abdurrob A, Lu J, Omenetto FG, et al. Transdermal delivery devices: fabrication, mechanics and drug release from silk. Small. 2013;9(21):3704-13.
150. Yan L, Raphael AP, Zhu X, Wang B, Chen W, Tang T, et al. Nanocomposite-strengthened dissolving microneedles for improved transdermal delivery to human skin. Adv Healthc Mater. 2014;3(4):555-64.
151. Kim M, Jung B, Park JH. Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin. Biomaterials. 2012;33(2):668-78.
152. Chen MC, Ling MH, Wang KW, Lin ZW, Lai BH, Chen DH. Near-infrared light-responsive composite microneedles for on-demand transdermal drug delivery. Biomacromolecules. 2015;16(5):1598-607.
153. Chen MC, Wang KW, Chen DH, Ling MH, Liu CY. Remotely triggered release of small molecules from LaB6@SiO2-loaded polycaprolactone microneedles. Acta Biomater. 2015;13:344-53.